| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d64af987d85a43a5b99672c11cd89c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99848cc6772698663c45ecd3cd1109b1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1051 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
| filingDate |
2003-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85eb19749ef984e897787d51acf95797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6caf22efbecb7d3a642fbf09dd33e6a1 |
| publicationDate |
2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004024938-A2 |
| titleOfInvention |
Β1,4-n-acetylgalactosaminyltransferases, nucleic acids and methods of use thereof |
| abstract |
β1,4-N-Acetylgalactosaminyltransferases (β4GaINAcTs) and nucleic acids encoding the β34GaINAcTs or proteins having (β34GaINAcT activity are described. The polynucleotides can be used to transform or transfect host cells for producing substantially pure forms of the enzyme, or for use in an expression system, or in vitro, for formation of a GaINAc β1,4 GIcNAc structure on proteins or peptides. Antibodies to the β4GaINAcTs and their use are also contemplated. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9988661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3354726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016170186-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11046988-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299759-B2 |
| priorityDate |
2002-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |